4.3 Article

Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Non-Alcoholic Fatty Liver Disease and Vascular Disease

Roberta Forlano et al.

Summary: Non-Alcoholic Fatty Liver Disease (NAFLD) is becoming a leading cause of liver disease globally, with cardiovascular disease (CVD) being the primary cause of morbidity and mortality in NAFLD patients. NAFLD has a significant impact on the development and progression of cardiovascular disease, and this review discusses strategies for screening CVD in high-risk populations.

CURRENT VASCULAR PHARMACOLOGY (2021)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study

Dong Hyun Sinn et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis

Yao-Yao Zhou et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Medicine, General & Internal

Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors US Preventive Services Task Force Recommendation Statement

Susan J. Curry et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Review Primary Health Care

Metabolic Syndrome Systems Thinking in Heart Disease

Ron Dommermuth et al.

PRIMARY CARE (2018)

Article Gastroenterology & Hepatology

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Stuart McPherson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Cardiac & Cardiovascular Systems

Agreement between heart failure patients and providers in assessing New York Heart Association functional class

Brent A. Williams et al.

HEART & LUNG (2017)

Article Gastroenterology & Hepatology

Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter

Vincent Wai-Sun Wong et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Thomas Karlas et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis

Dong Hyun Sinn et al.

GASTROENTEROLOGY (2016)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications

Sven M. Francque et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

Article Pharmacology & Pharmacy

Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD

Yun-hao Xun et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)

Article Gastroenterology & Hepatology

Clinical association between non-alcoholic fatty liver disease and the development of hypertension

Jae-Hong Ryoo et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Medicine, General & Internal

Clinical Significance of Non-Alcoholic Fatty Liver Disease as a Risk Factor for Prehypertension

Jae-Hong Ryoo et al.

JOURNAL OF KOREAN MEDICAL SCIENCE (2014)

Article Gastroenterology & Hepatology

The genetics of NAFLD

Quentin M. Anstee et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)